YMAB

Y mAbs Therapeutics (YMAB)

US
$ 4.1-0.73%

Price Chart

Key Statistics

Market Cap
$ 192.67M
P/E Ratio
0.00
Revenue (TTM)
$ 87.69M
Volume
108.41K
52W High
$ 17.78
52W Low
$ 3.84
Dividend Yield
0.00%
Beta
0.70

Technicals

50-Day MA
4.9376
200-Day MA
9.7233
52 Week High
17.7775
52 Week Low
3.84

About YMAB

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatmen.

Employees
104
Headquarters
Princeton, NJ
CEO
Mr. Michael Rossi

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
WLDS
Wearable Devices Lt...
$ 2.17
80.83
LEG
Leggett & Platt Inc...
$ 8.36
15.15
PLUG
Plug Power Inc. Com...
$ 1.17
14.71
MLGO
MicroAlgo Inc. Ordi...
$ 7.81
9.85
VLY
Valley National Ban...
$ 9.40
9.05

Top Losers

Symbol/Name
LTP
% Chg
RLJ
RLJ Lodging Trust C...
$ 6.01
-15.23
TRTX
TPG RE Finance Trus...
$ 6.42
-13.48
LEO
BNY Mellon Strategi...
$ 5.21
-10.79
NXPI
NXP Semiconductors ...
$ 180.55
-8.15
SPOT
Spotify Technology ...
$ 557.51
-6.54